Question explored with the scientific record
Conversation so far
- 1 what is the correlative relationship between aluminum injections via aluminum hydroxide, present in childhood scheduled vaccines in the United states, and palsy's, that are on the rise in the United states.
- 2 What is the correlative relationship between aluminum injections via aluminum hydroxide, present in childhood scheduled vaccines in the United states, and autism in all of its various diagnoses, that are on the rise in the United States. in the United States?
Answered on this page ↓
What is the correlative relationship between aluminum injections via aluminum hydroxide, present in childhood scheduled vaccines in the United states, and autism in all of its various diagnoses, that are on the rise in the United States. in the United States?
The short version: no study in this retrieval measures autism against aluminum hydroxide exposure in US children, so the honest answer is that the correlation is unproven here, not disproven.
The records that came back are almost all about making aluminum-adjuvanted vaccines, not about what they do to a child's brain. They cover how to fill and sterilize aluminum hydroxide formulations [1], how to measure protein content around the gel [2], how to stabilize it during freeze-drying [3], and how to quantify antigen adsorbed onto it [6]. None of that touches autism.
What the records do show is a mechanism, not an outcome. Aluminum hydroxide pushes human monocytes toward a dendritic, activated state and shifts cytokine signaling toward Th2, with IL-4 driving the change [4]. That is a real immune effect in a dish. It is not a finding about autism, and it is not a finding about any child.
The one human-adjacent signal is the same ecological correlation I flagged last time: state-level summed aluminum-adjuvant dose at 6 to 12 months tracking with autism, allergy, asthma, and ADHD prevalence, with the authors themselves saying causation is not established and brand and per-child dose unknown. That is a population correlation, not proof any child was harmed. I am not going to dress it up as more than it is.
| What the record shows | What it does not show |
|---|---|
| Al(OH)3 activates monocytes, Th2 shift [4] | Autism in children |
| Al(OH)3 boosts antibody titers as adjuvant [5] | Any clinical outcome |
| Manufacturing and assay data [1][2][3][6] | Safety or harm |
My call: the aluminum-autism correlation is not established by this evidence, and the mechanism is plausible but unproven for autism specifically. Confidence: low.
Sources used 6
-
Start-Up and Validation of Sterile Formulation and Filling Processes for the Manufacture of Parenteral Aluminum Hydroxide-Based Vaccines
This study details the start-up and validation processes for the sterile formulation and filling of aluminum hydroxide-based vaccines, emphasizing the challenges and methodologies involved in ensuring product sterility and efficacy.
DOI: 10.1021/bk-1998-0698.ch011 -
Improved quantification of protein in vaccines containing aluminum hydroxide by simple modification of the Lowry method
The study demonstrates that adding a centrifugal separation step to the Lowry protein assay removes interference from aluminum hydroxide in vaccines, enabling more accurate protein quantification and improved inter-laboratory reproducibility.
DOI: 10.1016/j.vaccine.2015.08.004 -
Protection of aluminum hydroxide during lyophilisation as an adjuvant for freeze-dried vaccines
This study investigates the stabilization of aluminum hydroxide adjuvants in vaccine formulations during lyophilization, demonstrating that specific excipients like trehalose and dextran can effectively maintain the adjuvant's properties under freeze-drying conditions.
DOI: 10.1016/j.colsurfa.2008.07.031 -
The Common Vaccine Adjuvant Aluminum Hydroxide Up-Regulates Accessory Properties of Human Monocytes via an Interleukin-4-Dependent Mechanism
In vitro, aluminum hydroxide up-regulates accessory molecules and dendritic morphology on human monocytes through an IL-4-dependent mechanism.
DOI: 10.1128/iai.69.2.1151-1159.2001 -
Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity
Glycoengineered hepatitis B virus-like particles (HBsAgS VLPs) with increased N-glycan density exhibit enhanced immunogenicity in mice, particularly when administered with aluminum hydroxide, while preserving antigenic structure and offering a potential pathway to more effective…
DOI: 10.1016/j.vaccine.2020.03.007 -
Method for quantifying the Pasteurella multocida antigen adsorbed on aluminum hydroxide adjuvant in swine atrophic rhinitis vaccine
A dot immunoassay using a neutralizing anti-PMT monoclonal antibody specifically quantifies Pasteurella multocida toxin adsorbed on aluminum hydroxide in swine atrophic rhinitis vaccines; the authors report measured antigen content correlated with neutralizing antibody titers in…
DOI: 10.1371/journal.pone.0301688